Medical-Grade Quality Pharmaceutical-grade nutrients administered by licensed staff in a supervised clinical setting
In contrast, while short-acting GLP-1 RAs did not show significant effects on MAKE in our cohort, it is important to note that lixisenatide has shown kidney benefits in the ELIXA trial 32
Accordingly, a reduced caloric intake has been observed in lean and obese individuals and in patients with T2D after exogenously administered GLP-1 during ad libitum meals
De Marchi, S., Zecchetto, S., Rigoni, A., Prior, M., Fondrieschi, L., Scuro, A., Rulfo, F., and Arosio, E